New York City Pharmacy is categorized under Mail Order Pharmaceuticals in New York City, NY and active since 1999.
New York City Pharmacy was established in 1999, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Ali Yasin, Owner at the company’s single location by writing to 206 1st Avenue, New York City, New York NY 10009 or by phoning (212) 253-8686. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | New York City Pharmacy |
Contact Person: | Ali Yasin, Owner |
Address: | 206 1st Avenue, New York City, New York 10009 |
Phone Number: | (212) 253-8686 |
Website Address: | nycprx.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Mail Order Pharmaceuticals |
SIC Code: | 5961 |
NAICS Code: | 4461100 |
Share This Business: |
New York City Pharmacy was started in 1999 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Ali Yasin, Owner for inquiries that concern New York City Pharmacy by calling the company number (212) 253-8686, as your correspondence is most welcome. Additionally, the physical location of the single location of New York City Pharmacy can be found at the coordinates 40.730315,-73.983244 as well as the street address 206 1st Avenue in New York City, New York 10009.
For its online presence, you may visit New York City Pharmacy’s website at nycprx.com and engage with its social media outlets through on Twitter and on Facebook.